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ABSTRACT
Accelerated Bone Formation in Distracted
Alveolar Bone after Injection of recombinant human 
Bone Morphogenetic Protein-2
Munkhdulam Terbish
The Graduate School Yonsei University
Department of Dentistry
(Directed by Professor Jung-Yul Cha, D.D.S., M.S., Ph.D)
This study was done to evaluate the effect of recombinant human bone 
morphogenic protein-2 (rhBMP-2) on enhancing the quality and quantity of 
regenerated bone when injected into distracted alveolar bone.
Sixteen adult beagle dogs were assigned to either the control or rhBMP-2 
group. After distraction was completed, an rhBMP-2 dose of 330 µg in 0.33 ml 
was injected slowly into the distracted alveolar crest of the mesial, middle, and 
distal parts of the alveolar bone in the experimental group. Histological and 
micro-computed tomography analyses of regenerated bone were done after 2 
and 6 weeks of consolidation.
After 6 weeks of consolidation, the vertical defect height of regenerated 
bone was statistically lower in the rhBMP-2 group (2.2 mm) than in the control 
group (3.4 mm) (P <0.05). Additionally, the width of the regenerated bone was 
significantly greater in the rhBMP-2 group (4.3 mm) than in the control group 
(2.8 mm) (P <0.05). The bone density and volume of regenerated bone in the 
vrhBMP-2 group were denser and greater, respectively, than in the control group 
after 6 weeks of consolidation (P <0.001).
Injection of rhBMP-2 into regenerated bone after a distraction osteogenesis 
procedure, significantly increased bone volume in the dentoalveolar distraction 
site, and improved both the width and height of the alveolar ridge and increased 
the bone density.
Key words: rhBMP-2, Bone regeneration, Distraction osteogenesis, Alveolar bone
distsraction osteogenesis.
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human Bone Morphogenetic Protein-2
Munkhdulam Terbish
The Graduate School Yonsei University
Department of Dentistry
(Directed by Professor Jung-Yul Cha, D.D.S., M.S., Ph.D)
I. Introduction
The possibility of bone lengthening by means of distraction osteogenesis
(DO) was first described by Codivilla 1905(Codivilla, 1905). Distraction 
osteogenesis is a surgical process used to reconstruct skeletal deformities and 
lengthen the long bones of the body(Ilizarov, 1989a, b).
Distraction osteogenesis regenerates new bone by the gradual separation of 
bony segments and the maturation of bone processed during the consolidation 
period, which makes the new bone strong enough to support the bone structure
(Paley et al.,1997). The technology of DO has been used mainly in the field of 
orthopedics (Yen, 1997).
In dental fields, DO have been applied to alveolar bone and the anterior 
maxillary complex and is known as interdental distraction or premaxillary DO
(Tong et al., 2003). These are the treatment choices for patients with cleft 
palate or constricted dentition (Choi et al., 2013). With this method, new 
2dentoalveolar bone structures are regenerated by transportation distraction of 
alveolar bone. The created alveolar bone provides space for aligning crowded
dentition (Tong et al., 2003), or the dentition can be restored by further 
rehabilitative treatments such as implant placement (Terbish et al.,2014).
Recently, alveolar bone DO has been applied to atrophic mandibular and 
maxillary alveolar ridges, and the alveolar segment can be distracted in the 
vertical and horizontal directions according to morphologic features of the 
atrophic ridge (Bianchi et al.,2008). Compared to bone grafts for the atrophic 
alveolar ridge, alveolar DO has been applied successfully for the augmentation of 
the height of the alveolar bone ridge where the amount of soft tissue uncovered 
may be limited, and the bone defect is complicated (Perry et al., 2012). Alveolar 
bone can be distracted in conjunction with the surrounding soft tissues. These 
adaptive changes reduce the risk of recurring infection in the bone defect and 
promote regeneration of the alveolar bone (Uckan et al., 2008).
However, the relapses after DO of the maxillofacial bone are still a major 
concern to clinicians (Choi et al., 2012). After completing DO, the distractor
should be stabilized as an anchorage unit to reduce postoperative relapse. For 
this purpose, an appliance needs to be maintained for long periods, but is often 
uncomfortable for the patient and may cause infection in the anchorage area
(Choi et al., 2012). The appliances can also fracture. A relapse rate of 10% to 
25% was reported for premaxillary distraction, and bone height relapse after 
alveolar distraction varies from 8.5% to 18% depending on the appliance type 
and surgical technique (Herford et al., 2007). Therefore, a distracted segment 
necessitates an over correction of 15% to 20%. As a result of relapse, the 
height of the alveolar bone distraction site is often not sufficient for dental 
implantation, leading to additional surgery to augment the alveolar bone height,
such as bone grafts or guided bone regeneration (Bianchi et al., 2008; Cortese et 
al., 2011).
3For this reason, there have been many attempts to accelerate the 
orthogenesis of the distraction to reduce both relapse and shorten consolidation
period (Francis et al., 2013). Previous studies report acceleration of bone 
formation in DO and bone healing by applying demineralized bone matrix
(Hatzokos et al.,2011; Song et al., 2004), growth factors (Ai-Aql et al., 2008; 
Huet al., 2007; Moore et al., 2009) and marrow-derived progenitor cells
(Verseijden et al., 2010) to the distraction site. 
Various carrier systems for recombinant human bone morphogenetic 
protein-2 (rhBMP-2) have been reported for distraction of long bones and 
maxillofacial bones, including a collagen sponge (Cochran et al.,2000; Sailhan et 
al., 2010) and chitosan hydrogel (Konas et al., 2009) during the surgical 
operation; sequential injection (Li et al., 2002) of rhBMP-2 at the site of 
distracted bone during the distraction period has also been reported. These
approaches showed acceleration of the osteogenic potential of bone formation 
and increased the stability of the regenerated bone structure (Rihn et al., 2009; 
Sailhan et al., 2010). However, the carrier delivery system required an 
additional flap to cover the surrounding tissue, and sequential injections can 
increase patients discomfort during the distraction period.
For this reason, trials of rhBMP-2 injections without a carrier system have 
been done at the end of the distraction phase. These trials reported that
rhBMP-2 injections could accelerate bone healing compared with conventional 
DO, suggesting that the consolidation period can be reduced. However, these
trials were performed for distraction osteogenesis (DO) of the long bone or 
mandible (Cheung et al., 2006). There are no reports as yet on the anatomical 
characteristics of the alveolar structures created when rhBMP-2 injections are 
applied after distraction osteogenesis (DO). This study evaluated the bone 
quality and quantity when rhBMP-2 was injected into distracted alveolar bone 
compared with the conventional alveolar DO procedure.
4II. Materials and methods
A. Animals and Surgery
Sixteen 16-to-18 month-old beagle dogs (weighing: 15-16 kg) were 
used. The dogs were caged individually and fed liquid food and water for two 
months. The dogs were divided into the control and rhBMP-2 groups. In each 
dog, a horizontal crestal incision was made, and a mucoperiosteal flap was 
raised in order to extract a maxillary canine tooth before the main surgical 
operation. All animal procedures were approved by the Institutional Review 
Board of the Committee of the Department of Laboratory Animal Medicine, 
Medical Research Center, Yonsei University College of Medicine (Y 09-120), 
Seoul, South Korea.
The dogs were divided into the following 2 groups: control group (n=8) and 
experimental group (n=8). The experimental protocol is shown in (Fig. 1). After 
a latency period of 7 days, distraction was started gradually at a rate of 0.8 mm 
twice daily until the dentoalveolar segment reached the opposite edge of the 
cleft by day 10. The alveolar distractor was fabricated with an orthodontic hyrax 
screw (Hyrax® Ispringen, Dentaurum, Germany), which allowed a maximum 
distraction of 8 mm at an expansion rate of 0.20 mm/quarter turns.
5Fig. 1. Experimental protocol for the sequential stages of the maxillary alveolar 
DO and the rhBMP-2 injection time.
Die stone models from alginate impressions were used to fabricate the 
distraction device consisted of an orthodontic hygienic-type Hyrax screw 
(Dentaurum, Ispringen, Germany). The vertical and horizontal osteotomies were 
performed to allow distraction of the first premolar segment into a bony defect
at the canine site and creation of a dentoalveolar transport segment containing 
the second premolar. A complete horizontal subapical osteotomy was performed 
7 mm apical to the cementoenamel junction (CEJ) of the first and second 
premolars, and a complete vertical interdental osteotomy was created between 
second and third premolars. 
The maxillary first, second premolars and first molar were etched with 37% 
phosphoric acid gel for 30 seconds. The crowns were filled with the 3M 
Filtek Supreme restorative composite resin (3M ESPE, St Paul, Minn) (Fig. 2).
6Fig. 2. Surgical procedure using a customized alveolar distractor on the 
maxillary arch, and quantitative analysis of osteogenesis in the regenerated bone.
A. Model distraction device. B. The osteotomy procedure for alveolar bone 
distraction. The removed bone is displaced in the extraction socket of the 
maxillary canine (white dotted box). The direction of movement of the 
segmental alveolar bone (blue arrow). C. Latency period maxillary alveolar 
segments including first and second premolars and first molar. D. After
distraction period. The space created in the alveolar bone after distraction was 
completed. rhBMP-2 was injected into the alveolar crest (blue point).
7After the distraction was completed, a 1 ml syringe was loaded with 330 µg 
rhBMP-2 (Cowellmedi, Busan, Korea) in 0.33 ml phosphate buffered saline 
(PBS). In the experimental group, 0.11 ml of the rhBMP-2 solution was injected 
slowly into each part (mesial, middle, and distal, respectively) of the distracted
alveolar crest of the alveolar bone (Fig. 1D). The sedative analgesics Zolazepam
with tiletamine (5 mg/kg) (Zoletil 50, Virbac Laboratories, Carros, France) and
Xylazine (0.2 mg/kg) (Rompun 2%, Bayer Healthcare Korea, Korea) were
administered during rhBMP-2 injection through an intravenous line placed in the
brachial vein.
B. Micro-computed Tomography Analysis
After 2 or 6 weeks of consolidation, the animals were sacrificed and the 
alveolar segments were scanned by micro-computed tomography (SkyScan 
micro-CT 1076, Bruker, Kontich, Belgium) at a voltage of 100 kV and a current 
of 100 mA with 36μm resolution (Fig. 3) (Cha et al., 2009). The frame 
averaging was set at 3 with rotational imaging of 360 degrees. Scanning data 
were reconstructed using NreconVer 1.5 (Nrecon v.1.5, Bruker).
Fig. 3. Skyscan micro-CT
8The bone parameters were analyzed by CT-An (CTAn v.1.13, Bruker) to
estimate bone density, bone volume (BV/TV) fraction, trabecular number (Tb.N), 
trabecular separation (Tb.Sp), and trabecular thickness (Tb.Th) for each 
consolidation period. Regenerated bone was divided into 3 volumes (mesial, 
middle, and distal), with each volume including 50 slices. The alveolar bone 
height and width of the regenerated bone were measured with Data Viewer 
Version 1.3.2 (DataViewer v.1.3.2, Bruker) (Fig. 4).
Fig. 4. Alveolar bone height and width of regenerate bone was measured at the 
mesial, middle and distal part of the regenerate. A. The height of the 
regenerated alveolar bone was measured from the osteotomy line (green line) to 
the alveolar crest of the mesial, middle, and distal parts of the regenerated bone 
area, respectively (orange arrows). Vertical bone defects after DO were 
measured in the middle of the regenerated alveolar ridge to the connecting line 
(yellow line) at the cementoenamel junction of the second premolar, and third 
premolar vertical lateral height (green line, osteotomy line). B. The width of the 
regenerated alveolar bone was measured at the mesial, middle, and distal parts 
of the regenerated bone, respectively (orange arrows), and in the middle.
9C. Tissue Preparation
The specimens obtained after sacrifice were fixed in 4% paraformaldehyde 
for 24 h and decalcified with Rapid-Cal immune (Rapid Cal Immuno, BBC 
Biochemical Mount Vernon, WA) for 2 weeks. Each maxillary alveolar bone was 
divided axially into 2 segments then embedded in paraffin. Sections that were 9 
microns thick were mounted on the SP 1600 microtome (SP 1600 microtome, 
Leica DFC 290, Leica, Nussloch, Germany) after staining with hematoxylin and 
eosin (H&E) (Figs. 7A through 7H). The histological examination was done 
using picrosirius red birefringence (PicroSirius, Sigma-Aldrich, St. Louis, MO)
to visualize collagen type І under polarized light (Figs. 7I through 7L) (Plate et 
al., 2014).
D. Statistical Analysis
The height and width of the regenerated bone were compared between 
controls and the rhBMP-2 group. The bone parameters between the control and 
rhBMP-2 groups were also compared. Statistical analyses were performed by 
using SPSS software (SPSS v.16, IBM. Armonk, NY). Nonparametric Wilcoxon 
signed rank tests were used to analyze differences between the control and 
rhBMP-2 groups.
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III. Results
A. Animal data
Among the 16 adult beagle dogs, inflammation was observed in one dog in 
each of the control and rhBMP-2 groups. Inflammation occurred during the 
distraction period prior to the injection of rhBMP-2, and was controlled after the 
distraction was complete in both dogs. 
B. Micro-Computed Tomography Results
Differences in new bone height and width were observed after 2 and 6 week 
of consolidation between the control and rhBMP-2 groups (Figs. 5 and 6). 
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Fig. 5. Three-dimensional features of the alveolar bone regenerated from the 
buccal, occlusal and lingual perspectives for the control and rhBMP-2 groups 
after 2 and 6 weeks of the consolidation. Vertical bone defects in the 
regenerated bone were comparable between the control and rhBMP-2 groups 
(white dotted line). Scale bars: 4 mm
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Fig.6. Representative sagittal and coronal images at the mesial, middle, and 
distal segments of the regenerated bone in the control and rhBMP-2 groups 
after 2 and 6 weeks of consolidation. The region of interest for the 3-
dimensional bone parametric analysis was defined as a red box. Scale bars: 4 mm.
After 2 weeks of consolidation, the median vertical defect height was 4.0 
mm and 2.2 mm for the control and rhBMP-2 groups, respectively. After 6 
weeks of consolidation, the median vertical defect height was 3.4 mm and 2.2 
mm for the control and rhBMP-2 groups, respectively, with significant 
differences over each period. The median alveolar width in the middle of the 
regenerated bone after 6 weeks of consolidation was 2.8 mm and 4.3 mm for the 
control and rhBMP-2 groups, respectively, with significant differences between 
the two groups. The alveolar height ratio of the regenerated bone after 6 weeks 
of consolidation was 55.7% and 82.2%, and the alveolar width ratio was 61.9% 
and 78.1% for the control and rhBMP-2 groups, respectively, with significant 
differences between the two groups (P <0.05) ( Table 1).
13
Table 1. The height of vertical defect and width of regenerated bone in the control and rhBMP-2 groups after 2 
and 6 weeks of consolidation.
NS, not significant; Med, Median. *Significant difference between the control and rhBMP-2.
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Table 2.  Three-dimensional histomorphometric analyses of the middle and distal aspects of the regenerated 
alveolar bone in the control and rhBMP-2 groups after 2 and 6 weeks consolidation
NS, not significant; Med, Median.  *Significant difference between the control and rhBMP-2 group(P <0.05).
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The bone density, BV/TV, Tb.N, Tb.Sp, and Tb.Th in the middle of the 
regenerated bone were lower than those of the distal segments of the 
regenerated bone in both groups and after each consolidation period (Table 2). 
After 6 weeks, the bone density in the middle of the regenerated bone was 
283.5 mg/cm3 and 621.8 mg/cm3, the BV/TV was 28.1% and 42.9 %, and the 
Tb.Th was 0.13 mm and 0.23 mm for the control and rhBMP-2 groups, 
respectively, showing significant differences between the two groups
(P <0.001) (Table 2).
C. Histological Results 
After 2 weeks of consolidation in the control group, the histologic section 
demonstrated new bone formation in the host bone, with margins of fibrous tissue in 
the center of the gap. Picrosirius red stained images showed dense fibrous tissue 
(green color) (Fig. 7I). For the rhBMP-2 group after 2 weeks of consolidation, 
bone trabeculae could be seen in the distraction area with spindle-shaped 
fibroblasts surrounding them. The distracted bone gap was almost completely filled 
by newly formed bone. However, some fibrous tissue was observed in the center of 
the distracted bone gap and between the newly formed bone islands. Some 
osteoblasts were observed in the new bone, which looked like a reticular structure 
(Fig. 7J). After 6 weeks of consolidation, osteoblasts and osteoclasts in the 
rhBMP-2 group were seen around the area of angiogenesis (Fig. 7L).
Using picrosirius red stained images and polarized light microscopy, a collagen
matrix was evident in the new bone. These were highlighted to distinguish the 
lamellar and woven bone. Sections stained with picrosirius red indicated that 
significant woven bone formation had occurred after 2 weeks of consolidation in 
both the control and rhBMP-2 groups (Fig. 7I and 7J). The orientation of the 
collagen was mature, showing the increased organization of new bone.
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Fig. 7. Alveolar distraction site in the maxilla after 2 and 6 weeks of consolidation. 
Slides were stained with H&E and picrosirius red. A. Control group after 2 
weeks of consolidation. Histologic sections show new bone (NB) formation 
located in the host bone (HB) and margins with fibrous tissue (FT) in the center 
of the gap. BT=bone trabeculae. B. rhBMP-2 group after 2 weeks of consolidation. 
The distracted bone gap is almost completely occupied by newly formed bone. C. 
Control group after 6 weeks of consolidation. D. rhBMP-2 group after 6 weeks of 
consolidation. E through H. High magnification of H&E stained images showing 
osteoblasts, osteocytes, and fibrous tissue (FT), Haversian canal (HC). I through
L. High magnification of picrosirius red stained images under polarized light 
microscopy. A collagen fiber was evident in the new bone. Magnification 
bars=A through D, ×4 objective: 500μm; E through L, ×40 objective: 50 μm.
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Ⅵ. Discussion
In this study, the height and width of the regenerated alveolar bone differed 
depending on the location (middle, distal, or medial) of the regenerated alveolar 
bone. Both the control and rhBMP-2 groups showed narrower width (61.9%-
78.1%) and shorter vertical height (55.7%-82.2%) in the middle part of the 
regenerated bone compared with the mesial and distal segments after 6 weeks 
of consolidation (Table 1). This characteristic of the regenerated bone resulted 
in an alveolar ridge that was of insufficient width for prosthetic orthodontic 
implantation, which would require a bone graft in the regenerated site.
However, a previous study reported that bone regeneration in the 
dentoalveolar distraction of the mandible showed no differences in healing 
pattern between the mesial, middle, and distal segments (Moore et al.,2011).
Alveolar bone distractions in the maxilla seem to be difficult compared with 
those of the mandible; but the difference has not yet been reported.
The rhBMP-2 group showed significantly higher BV/TV in the regenerated 
bone compared with the control group after 6 weeks of consolidation. The 
BV/TV in the middle of the regenerated bone was 28.1% and 42.9 %, and the 
trabecular thickness was 0.13 mm and 0.23 mm in the control and rhBMP-2 
groups, respectively, with significant differences between the two groups (Table 
2). As these results suggest, rhBMP-2 increases the total amount of newly-
formed bone (Ozdemir et al., 2014; Zheng et al., 2006). In a femoral fracture 
model in rats, a single, local, percutaneous injection of rhBMP-2 accelerated 
fracture healing (Einhorn et al., 2003). rhBMP-2 injection into distracted 
alveolar bone showed similar results in a previous study (Yasko et al., 1992). 
The bone mineral density of the two groups was significantly different at 283.5 
mg/cm3 and 621.9 mg/cm3 for the control and rhBMP-2 groups, respectively, 
after 6 weeks of consolidation (Table 2). These results suggest that a more 
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mature pattern of bone density was present in the rhBMP-2 group after 6 
weeks of consolidation. 
Bone morphogenic proteins (BMPs) exhibit osteoinductive ability that can 
enhance bone formation or consolidationduring the consolidation period. rhBMP-
2 is reported to affect the rate of callus formation and mineralization, exhibiting 
the strongest osteoinductive ability among these proteins (Campisi et al., 2003; 
Li et al., 2002). The micro-computed tomography data showed that the quality 
of the regenerated bone in the rhBMP-2 group was much better, both 
quantitatively and qualitatively, compared with the control group.
rhBMP-2 has been administered to osteogenesis sites with a polymer-coated 
gelatin sponge, collagen sponge, chitosan hydrogel, or by injection at the 
distraction site of orthogenesis in long bones (Sailhan et al., 2010). Collagen and 
gelatin promote tissue regeneration, so the effect of pure rhBMP-2 could not be 
assessed in previous reports (Rihn et al., 2009). In the current study, rhBMP-2 
was injected directly into the distracted side after distraction was finished. The 
direct injection method after the distraction procedure as the advantage of 
simplicity, easy dose calculation, and increased predictability. It was expected that
the rhBMP-2 material would diffuse into the bony callus, which is composed of 
mineralized extracellular matrix generated during the DO procedure, and that it 
would act as a reservoir for the injection material. However, a limitation of this 
study was that the diffusion and clearance of rhBMP-2 into the target tissue area 
after injection was not investigated. When a collagen carrier system was used, 
retention of rhBMP-2 in a rat model was reported as less than 5% 14 days after 
implantation (Kempen et al., 2008; Uludag et al., 1999). Therefore, when it is 
released without controlled diffusion, rhBMP-2 clearance might be more rapid 
than the bone-induction response of the host. Furthermore, the optimal release 
profile may vary in different animal species (Zhang et al.,2009). Nevertheless, the 
rhBMP-2 group in our present model showed significantly increased bone volume, 
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including increased bone density, after 6 weeks of consolidation, which supports 
the notion that retention of rhBMP-2 in distracted alveolar bone tissue is 
prolonged and within an expected residence time.
Local rhBMP-2 injection was done directly after the distraction phase. In 
previous studies applying rhBMP-2 delivery, the BMP-2 concentration was not 
maintained in the area of the bone defect for a period of time sufficient to recruit 
osteoprogenitor cells to the target site and allow them to differentiate into 
osteoblasts because of its short biological half-life (Uludag et al., 1999). For 
this reason, use of a carrier system or synthetic polymer coating for sustained 
delivery of BMP-2 was introduced to achieve prolonged osteogenic induction in 
the target area (Kempen et al., 2008). In our present model, the area where the 
rhBMP-2 was injected into the distracted alveolar bone tissue was composed of 
chondrocyte like cells and fibroblasts as well as differentiating osteoblasts that 
deposit osteoid along collagen bundles (Ai-Aql et al., 2008). Therefore, we 
speculated that the local injection of rhBMP-2 could immediately affect the 
differentiation of osteogenic cells within tissue that is abundant in collagen. 
In the maxillary bone of the beagle dog, the sinus is elongated to the inter
root space. Therefore, we had to cut the root tip during the surgery because the 
horizontal cutting line under the sinus level was ovoid-shaped. In humans, the 
sinus is in a different location than that of the animal model, so horizontal 
osteotomy could be performed 3 to 5 mm away from the dental root apex with a 
cutting saw for the DO procedure (Liou et al.,2000). Root damage was intended 
in our study model, but it is easy to control inflammation in an experimental 
animal without perforating the sinus. For this reason, no complications were 
observed in our model during or after the DO procedure.
In this study, an osteoinductive effect was achieved at a lower dosage of 
rhBMP-2 (Sciadini et al., 2000). Previous studies showed a wide range of doses 
of BMP, ranging from 20-3000 µg/kg depending on the size of the defect, animal 
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species, and location of the distraction (Carreira et al., 2014; Zheng et al., 2006). 
Some studies have shown that the amount of bone induced by BMPs depends on
the dose of BMP and the length of the consolidation period. However, excessive 
doses of BMP can cause swelling, inflammation, and a higher cancer risk, 
emphasizing the need for refined guidelines when using BMP clinically (Carreira 
et al., 2014; Zheng et al., 2006). In this study, an osteoinductive effect was 
achieved at a lower dose of rhBMP-2. We speculate that inflammation was not 
observed because we did not use carriers to deliver the rhBMP-2 and because 
we reduced the amount of rhBMP-2 injected compared with previous studies. 
In the present study, the amount of rhBMP-2 injected (330 µg) represents 
about 1/15 of the total volume of the regenerated bone, with a small dosage of 
rhBMP-2 relative to previous studies. This dose activated significant bone 
formation at the regeneration site. Future experiments should include a 
comparative study of bone formation after direct injection of rhBMP-2 to 
determine if the regenerative activity is dependent on the dose of rhBMP-2.
The bone parameter analysis of the new bone trabeculae agreed with the 
histologic examination. The bone remodeling process, characterized by 
osteoclasts and osteoblasts on the newly formed bone surfaces, was evident 
through the consolidation period. After 2 and 6 weeks of consolidation, there 
was active bone formation within the distracted gap in the rhBMP-2 group. New 
bone volume was significantly higher in the rhBMP-2 group after 6 weeks of 
consolidation compared with the control group, and the vertical defect of new 
bone in the middle of the regenerated bone was significantly lower in the 
rhBMP-2 group after 6 weeks of consolidation compared with the control group.
Histologic slides stained with picrosirius red indicated that significant mature 
bone formation had occurred after 6 weeks of consolidation in the BMP-2 group. 
This finding reflects vigorous bony regeneration in the alveolar bone DO after 
treatment with rhBMP-2.
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The results of the present study after alveolar bone DO coincide with the 
results found in a prospective study by Chiapasco et al. and Jensen et al
(Chiapasco et al., 2004; Jensen et al., 2002). These authors reported on the 
quality and quantity of regenerated bone after the consolidation period directly 
related to bony relapse, suggesting that an increase in the consolidation period 
could reduce the rate of relapse. The accelerated bone formation that occurs 
after treatment with rhBMP-2, as found in our study, could improve the stability 
of the distracted alveolar bone and decrease the rate of relapse, without 
increasing the length of the consolidation period.
It was an interesting finding that the histological characteristic at 8 weeks of 
consolidation period in previous study related with mandibular DO using 
experimental dogs, was similar to histological finding at the 6 weeks of 
consolidation period in the present study (Cope JB et al., 2000). Meanwhile, 
after 2 weeks of consolidation, rhBMP-2 group showed classic 3 zones which 
were composed of fibrous tissue (FT) bounded by bony trabeculae (BT) 
originating from the host bone (HB) margins. The distracted bone gap was
almost completely occupied by newly formed bone at 2 weeks of consolidation 
period for rhBMP-2 group. Surprisingly after 6 weeks of consolidation, 
histological section of regeneration was observed with almost complete absence 
of interzone, and showing harvasian canal in newly formed bone, which might 
indicate that the consolidation period can be reduced with rhBMP-2 injection 
compared with conventional methods.
This study supports that rhBMP-2 is effective in enhancing the 
consolidation of regenerated alveolar bone. However, we did not directly 
compare the relapse rates between the control and rhBMP-2 groups. In addition, 
our experimental model was limited to the maxillary bone. A previous study 
using mandibular bone showed smaller vertical defects compared with our 
results. This difference may result from different bone formation activity 
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depending on the location of the distraction site (Cope et al.,2002). Therefore, in 
the future the rhBMP-2 injection method will need to be applied to mandibular 
bone to evaluate whether rhBMP-2 can enhance bone formation in different 
bone areas.
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Ⅴ. Conclusion
rhBMP-2 injection after a DO procedure significantly increases bone volume 
in regenerated dentoalveolar structures after 6 weeks of consolidation and 
improved both the width and height of the alveolar ridge as well as increasing 
the bone density. Therefore, rhBMP-2 injection accelerates bone formation, and 
results in adequate bone morphology and volume. 
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국 문 요 약
치조골골신장부위의재조합인간골형성단백질 -
2 주입후골형성촉진
Munkhdulam Terbish
연세대학교 대학원 치의학과
(지도교수 차정열)
본 연구는 신장된 치조골에 rhBMP-2 를 주입했을 때, rhBMP-2 가 재생된 뼈의
골질과 골량에 미치는 효과를 평가하기 위한 것이다. 
열여섯 마리의 성체 beagle dog 을 대조군과 rhBMP-2 그룹으로 나누었다. 치조골
신장술 후, 실험군에서 신장된 치조골의 근심, 중앙, 원심 측 치조정에 330 µg 의
rhBMP-2 가 포함된 0.33 ml 의 용액을 천천히 주입하였다. 2 주, 6 주의 골 경화기
후에 재생된 골에서 조직학적 분석과 마이크로 CT 분석을 시행 하였다.
6 주의 골 경화기 후, 재생된 골의 수직적 결손이 대조군 (3.4 mm) 에 비해
rhBMP-2 군 (2.2 mm) 에서 유의하게 낮았다 (P<0.05). 또한, 재생골의 폭은
대조군 (2.8 mm) 보다 rhBMP-2 군 (4.3 mm) 에서 유의하게 높았다 (P<0.05). 
6 주의 골경화기 후에 rhBMP-2 군은 대조군에 비해 재생된 골의 골밀도가 더
높았고, 골량은 더 컸다 (P <0.001). 
골 신장술 후 재생된 골에 rhBMP-2 를 주입함으로 골경화기 6 주째 신장된
부분의 골량이 유의하게 증가하였으며, 치조제의 폭경과 높이가 향상되었고, 골질도
증가되었다.
핵심되는 말: rhBMP- 2, 골 재생, 뼈 조직, 골 신장술, 치조골 신장술, 골 형성.
